Cargando…
Can Biomarkers Identify Women at Increased Stroke Risk? The Women's Health Initiative Hormone Trials
OBJECTIVE: The Women's Health Initiative hormone trials identified a 44% increase in ischemic stroke risk with combination estrogen plus progestin and a 39% increase with estrogen alone. We undertook a case-control biomarker study to elucidate underlying mechanisms, and to potentially identify...
Autores principales: | Kooperberg, Charles, Cushman, Mary, Hsia, Judith, Robinson, Jennifer G, Aragaki, Aaron K, Lynch, John K, Baird, Alison E, Johnson, Karen C, Kuller, Lewis H, Beresford, Shirley A. A, Rodriguez, Beatriz |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891725/ https://www.ncbi.nlm.nih.gov/pubmed/17571161 http://dx.doi.org/10.1371/journal.pctr.0020028 |
Ejemplares similares
-
Impact of Cyclooxygenase Inhibitors in the Women's Health Initiative Hormone Trials: Secondary Analysis of a Randomized Trial
por: Hsia, Judith, et al.
Publicado: (2006) -
Low-Fat Dietary Pattern and Cancer Mortality in the Women’s Health Initiative (WHI) Randomized Controlled Trial
por: Chlebowski, Rowan T, et al.
Publicado: (2019) -
Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative
por: Cushman, Mary, et al.
Publicado: (2018) -
Taking action to advance the study of race and ethnicity: the Women’s Health Initiative (WHI)
por: Garcia, Lorena, et al.
Publicado: (2022) -
Correction: Taking action to advance the study of race and ethnicity: the Women’s Health Initiative (WHI)
por: Garcia, Lorena, et al.
Publicado: (2022)